CN106188411A - A kind of PEG type polythiourethane acrylic acid compound hydrogel material and its preparation method and application - Google Patents
A kind of PEG type polythiourethane acrylic acid compound hydrogel material and its preparation method and application Download PDFInfo
- Publication number
- CN106188411A CN106188411A CN201610542009.4A CN201610542009A CN106188411A CN 106188411 A CN106188411 A CN 106188411A CN 201610542009 A CN201610542009 A CN 201610542009A CN 106188411 A CN106188411 A CN 106188411A
- Authority
- CN
- China
- Prior art keywords
- polythiourethane
- peg
- type
- acrylic acid
- hydrogel material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 78
- 239000000463 material Substances 0.000 title claims abstract description 78
- -1 acrylic acid compound Chemical class 0.000 title claims abstract description 76
- 229920002578 polythiourethane polymer Polymers 0.000 title claims abstract description 49
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 title claims abstract description 23
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 69
- 239000002131 composite material Substances 0.000 claims abstract description 59
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims abstract description 57
- 239000004810 polytetrafluoroethylene Substances 0.000 claims abstract description 57
- 239000000178 monomer Substances 0.000 claims abstract description 51
- 239000000243 solution Substances 0.000 claims abstract description 47
- 239000002243 precursor Substances 0.000 claims abstract description 45
- 239000002904 solvent Substances 0.000 claims abstract description 45
- 102100026735 Coagulation factor VIII Human genes 0.000 claims abstract description 33
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 claims abstract description 33
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims abstract description 33
- 239000011259 mixed solution Substances 0.000 claims abstract description 30
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims abstract description 13
- 150000002148 esters Chemical class 0.000 claims abstract description 13
- 125000005442 diisocyanate group Chemical group 0.000 claims abstract description 11
- 210000004087 cornea Anatomy 0.000 claims abstract description 9
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 7
- 239000007943 implant Substances 0.000 claims abstract description 4
- 238000006116 polymerization reaction Methods 0.000 claims abstract description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 56
- DFOGGJMYYQUURK-UHFFFAOYSA-N 2,2-bis(sulfanyl)acetic acid Chemical compound OC(=O)C(S)S DFOGGJMYYQUURK-UHFFFAOYSA-N 0.000 claims description 35
- 229910052786 argon Inorganic materials 0.000 claims description 28
- 238000003756 stirring Methods 0.000 claims description 27
- 238000006243 chemical reaction Methods 0.000 claims description 23
- 239000000499 gel Substances 0.000 claims description 16
- 238000000502 dialysis Methods 0.000 claims description 15
- HWSSEYVMGDIFMH-UHFFFAOYSA-N 2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical group CC(=C)C(=O)OCCOCCOCCOC(=O)C(C)=C HWSSEYVMGDIFMH-UHFFFAOYSA-N 0.000 claims description 14
- RIWRBSMFKVOJMN-UHFFFAOYSA-N 2-methyl-1-phenylpropan-2-ol Chemical group CC(C)(O)CC1=CC=CC=C1 RIWRBSMFKVOJMN-UHFFFAOYSA-N 0.000 claims description 14
- 238000010526 radical polymerization reaction Methods 0.000 claims description 14
- 239000007787 solid Substances 0.000 claims description 13
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 claims description 10
- 229920002523 polyethylene Glycol 1000 Polymers 0.000 claims description 10
- 239000005058 Isophorone diisocyanate Substances 0.000 claims description 8
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 claims description 8
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 claims description 8
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 claims description 8
- 229920002582 Polyethylene Glycol 600 Polymers 0.000 claims description 6
- 229920002593 Polyethylene Glycol 800 Polymers 0.000 claims description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 229920002554 vinyl polymer Polymers 0.000 claims description 5
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims 1
- 229920001021 polysulfide Polymers 0.000 claims 1
- 239000005077 polysulfide Substances 0.000 claims 1
- 150000008117 polysulfides Polymers 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 55
- 239000002202 Polyethylene glycol Substances 0.000 abstract description 7
- PSYGHMBJXWRQFD-UHFFFAOYSA-N 2-(2-sulfanylacetyl)oxyethyl 2-sulfanylacetate Chemical compound SCC(=O)OCCOC(=O)CS PSYGHMBJXWRQFD-UHFFFAOYSA-N 0.000 abstract 1
- 239000002861 polymer material Substances 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- 230000008859 change Effects 0.000 description 21
- 238000009210 therapy by ultrasound Methods 0.000 description 19
- 239000002994 raw material Substances 0.000 description 15
- 239000007864 aqueous solution Substances 0.000 description 12
- 239000007789 gas Substances 0.000 description 10
- 239000004971 Cross linker Substances 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 6
- 239000004814 polyurethane Substances 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- OWIKHYCFFJSOEH-UHFFFAOYSA-N Isocyanic acid Chemical compound N=C=O OWIKHYCFFJSOEH-UHFFFAOYSA-N 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- XLJMAIOERFSOGZ-UHFFFAOYSA-N anhydrous cyanic acid Natural products OC#N XLJMAIOERFSOGZ-UHFFFAOYSA-N 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000001491 myopia Diseases 0.000 description 2
- 230000004379 myopia Effects 0.000 description 2
- VSZSIEBALNXIFG-UHFFFAOYSA-N 2-hydroxyethyl 2,2-bis(sulfanyl)acetate Chemical compound OCCOC(=O)C(S)S VSZSIEBALNXIFG-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010020675 Hypermetropia Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 201000009310 astigmatism Diseases 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 201000006318 hyperopia Diseases 0.000 description 1
- 230000004305 hyperopia Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- 201000010041 presbyopia Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229940071127 thioglycolate Drugs 0.000 description 1
- CWERGRDVMFNCDR-UHFFFAOYSA-M thioglycolate(1-) Chemical compound [O-]C(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-M 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F283/00—Macromolecular compounds obtained by polymerising monomers on to polymers provided for in subclass C08G
- C08F283/006—Macromolecular compounds obtained by polymerising monomers on to polymers provided for in subclass C08G on to polymers provided for in C08G18/00
- C08F283/008—Macromolecular compounds obtained by polymerising monomers on to polymers provided for in subclass C08G on to polymers provided for in C08G18/00 on to unsaturated polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/46—Polymerisation initiated by wave energy or particle radiation
- C08F2/48—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/30—Low-molecular-weight compounds
- C08G18/38—Low-molecular-weight compounds having heteroatoms other than oxygen
- C08G18/3855—Low-molecular-weight compounds having heteroatoms other than oxygen having sulfur
- C08G18/3876—Low-molecular-weight compounds having heteroatoms other than oxygen having sulfur containing mercapto groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/67—Unsaturated compounds having active hydrogen
- C08G18/671—Unsaturated compounds having only one group containing active hydrogen
- C08G18/672—Esters of acrylic or alkyl acrylic acid having only one group containing active hydrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/30—Sulfur-, selenium- or tellurium-containing compounds
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/04—Contact lenses for the eyes
- G02C7/049—Contact lenses having special fitting or structural features achieved by special materials or material structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Ophthalmology & Optometry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Dispersion Chemistry (AREA)
- Optics & Photonics (AREA)
- General Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明属于高分子材料领域,具体涉及一种PEG型聚硫氨酯‑丙烯酸复合水凝胶材料及其制备方法和应用。该方法包括如下步骤:S1.以DMF为溶剂,二巯基乙酸聚乙二醇酯与二异氰酸酯类单体反应生成聚硫氨酯,再加入HEMA,反应后得双键封端的PEG型聚硫氨酯;S2.取上述双键封端的PEG型聚硫氨酯与丙烯酸单体溶于DMF中,超声处理得混合液,向混合液中加入光引发剂和交联剂,再次超声使之成为透明的前驱体溶液;S3.将上述前驱体溶液倒在一块聚四氟乙烯板并盖上另一块板,使用紫外光照射引发聚合,即得PEG型聚硫氨酯‑丙烯酸复合水凝胶材料。本发明提供的复合水凝胶材料具有高平衡含水率和高折射率,在作为软质隐形眼镜的镜体材料或人工眼角膜的植入材料方面有潜在应用。
The invention belongs to the field of polymer materials, and in particular relates to a PEG-type polythiourethane-acrylic acid composite hydrogel material and its preparation method and application. The method comprises the following steps: S1. Using DMF as a solvent, polyethylene glycol dimercaptoacetate reacts with diisocyanate monomers to generate polythiourethane, then adds HEMA, and reacts to obtain PEG-type polythiourethane terminated by double bonds Ester; S2. Take the PEG-type polythiourethane terminated by the above-mentioned double bond and acrylic acid monomer and dissolve it in DMF, and ultrasonically treat the mixed solution, add photoinitiator and crosslinking agent to the mixed solution, and ultrasonically make it transparent S3. Pour the above precursor solution on a polytetrafluoroethylene plate and cover another plate, and use ultraviolet light to initiate polymerization to obtain a PEG-type polythiourethane-acrylic acid composite hydrogel material. The composite hydrogel material provided by the invention has a high equilibrium water content and a high refractive index, and has potential applications as a lens body material of a soft contact lens or an implant material of an artificial cornea.
Description
技术领域technical field
本发明属于高分子材料领域,具体涉及一种PEG型聚硫氨酯-丙烯酸复合水凝胶材料及其制备方法和应用。The invention belongs to the field of macromolecular materials, and in particular relates to a PEG-type polythiourethane-acrylic acid composite hydrogel material and its preparation method and application.
背景技术Background technique
眼科疾病在医学上属于大病种,目前已了解的眼科疾病至少有数十种,最常见的包括白内障、青光眼、近视、远视、老花、散光等,在各类眼科疾病中,最常见的是近视,危险性最高的是白内障。最近三十年中,随着各类新型生物医用材料和新型医疗激光设备等的开发和应用,眼科医疗器械市场得到了飞速发展,如角膜接触镜、人工晶状体、人工角膜、新型防护眼镜片粘弹性体等。Ophthalmic diseases are major diseases in medicine. At least dozens of ophthalmic diseases have been known so far. The most common ones include cataract, glaucoma, myopia, hyperopia, presbyopia, astigmatism, etc. Among various ophthalmic diseases, the most common Is myopia, the highest risk is cataract. In the past three decades, with the development and application of various new biomedical materials and new medical laser equipment, the ophthalmic medical device market has developed rapidly, such as corneal contact lenses, intraocular lenses, artificial corneas, and new protective glasses. Elastomers, etc.
水凝胶是一类具有亲水基团,能吸收大量的水但是能继续保持其原有结构而不溶于水的三维网络结构的聚合物。水凝胶类似于生命组织材料,表面粘附蛋白质及细胞能力很弱,在与血液、体液及人体组织相接触时,表现出良好的生物相容性,它既不影响生命体的代谢过程,代谢产物又可以通过水凝胶排出它具有优异的生物相容性,广泛的应用于生物医用材料。聚氨酯(PU)具有良好的生物相容性和优良的物理机械性能,对人体具有良好的生理可接受性,并且可以保持长期人体植入的稳定性,通过改变分子链中软硬段的组成可以改变聚氨酯的物理化学性能。由PU聚合物制备所得的PU水凝胶综合了水凝胶和PU两者的优点,引起人们很大的研究兴趣,并已经在生物医学领域中得到良好的应用。Hydrogel is a kind of polymer with hydrophilic groups, which can absorb a large amount of water but can continue to maintain its original structure and insoluble three-dimensional network structure in water. Hydrogel is similar to living tissue materials, and its surface adhesion to proteins and cells is very weak. When in contact with blood, body fluids and human tissues, it shows good biocompatibility. It does not affect the metabolic process of living organisms. The metabolites can be discharged through the hydrogel, which has excellent biocompatibility and is widely used in biomedical materials. Polyurethane (PU) has good biocompatibility and excellent physical and mechanical properties, has good physiological acceptability to the human body, and can maintain the stability of long-term human implantation. By changing the composition of soft and hard segments in the molecular chain, it can Change the physical and chemical properties of polyurethane. The PU hydrogel prepared from PU polymer combines the advantages of both hydrogel and PU, which has aroused great research interest and has been well applied in the field of biomedicine.
不管是人工眼角膜还是角膜接触镜都对材料的折射率都有一定的要求,提高材料折射率的办法有很多,其中方法之一是可以在聚合物中引入高摩尔折光系数和较小分子体积的硫、卤素元素(除氟外)、芳环、磷原子、重金属离子、稠环等。高水含量的水凝胶折射率低的最主要的一个原因是由于水的折射率低(1.33),如果能将水凝胶里面的自由水通过一定的作用力固定起来,必然能进一步提高水凝胶的折射率。Both the artificial cornea and the contact lens have certain requirements on the refractive index of the material. There are many ways to increase the refractive index of the material. One of the methods is to introduce a high molar refractive index and a small molecular volume into the polymer. Sulfur, halogen elements (except fluorine), aromatic rings, phosphorus atoms, heavy metal ions, condensed rings, etc. One of the most important reasons for the low refractive index of hydrogels with high water content is due to the low refractive index of water (1.33). If the free water in the hydrogel can be fixed by a certain force, it will inevitably further improve the water content. The refractive index of the gel.
所以,本发明提供一种具有高折射率和高含水量的PEG型聚硫氨酯-丙烯酸复合水凝胶材料,本发明利用不同的异氰酸单体,验证芳香结构和脂肪结构对材料折光率和平衡含水量的影响,同时利用不同分子量的PEG,得到不同的分子链长短的一系列水凝胶,研究氢键强度对聚合物的折射率和平衡含水量的影响。所制备的PEG型聚硫氨酯-丙烯酸复合水凝胶材料的折射率比人眼角膜高,而且含水量也和人眼角膜比较相近。Therefore, the present invention provides a PEG-type polythiourethane-acrylic acid composite hydrogel material with high refractive index and high water content. The present invention utilizes different isocyanic acid monomers to verify that the aromatic structure and aliphatic structure affect the refraction of the material. The influence of the ratio and the equilibrium water content, at the same time, using PEG with different molecular weights, a series of hydrogels with different molecular chain lengths were obtained, and the influence of the hydrogen bond strength on the refractive index and the equilibrium water content of the polymer was studied. The prepared PEG polythiourethane-acrylic acid composite hydrogel material has a higher refractive index than the human cornea, and its water content is similar to that of the human cornea.
发明内容Contents of the invention
针对现有技术中的不足,本发明所要解决的技术问题是提供一种PEG型聚硫氨酯-丙烯酸复合水凝胶材料及其制备方法和应用,该PEG型聚硫氨酯-丙烯酸复合水凝胶材料同时具有高折射率和高含水量。Aiming at the deficiencies in the prior art, the technical problem to be solved by the present invention is to provide a PEG type polythiourethane-acrylic acid composite hydrogel material and its preparation method and application, the PEG type polythiourethane-acrylic acid composite hydrogel material Gel materials have both a high refractive index and a high water content.
本发明解决上述技术问题的技术方案如下:一种PEG型聚硫氨酯-丙烯酸复合水凝胶材料及其制备方法,其特征在于,包括如下步骤:The technical solution of the present invention to solve the above-mentioned technical problems is as follows: a PEG type polythiourethane-acrylic acid composite hydrogel material and its preparation method, is characterized in that, comprises the following steps:
S1.以DMF为溶剂,二巯基乙酸聚乙烯醇酯单体与二异氰酸酯类单体反应生成PEG型聚硫氨酯,再加入封端剂HEMA,反应后得到双键封端的PEG型聚硫氨酯;S1. Using DMF as a solvent, polyvinyl dimercaptoacetate monomers react with diisocyanate monomers to generate PEG-type polythiourethane, and then add end-capping agent HEMA to obtain double-bond-terminated PEG-type polythiourethane after the reaction ester;
S2.取适量S1制得的双键封端的PEG型聚硫氨酯、丙烯酸单体溶于适量DMF中,首次超声处理得混合液,向所述混合液中加入适量光引发剂和交联剂,再次超声处理,使之成为透明的前驱体溶液;S2. Take an appropriate amount of double bond-terminated PEG-type polythiourethane and acrylic acid monomers prepared by S1 and dissolve them in an appropriate amount of DMF, and first ultrasonically treat the mixed solution, and add an appropriate amount of photoinitiator and crosslinking agent to the mixed solution , sonicate again to make it a transparent precursor solution;
S3.将S2中的前驱体溶液倒在一块聚四氟乙烯板上并在其上压上另一块聚四氟乙烯板,使用紫外光透过所述聚四氟乙烯板照射所述前驱体溶液,引发自由基聚合使其凝胶化,即得PEG型聚硫氨酯-丙烯酸复合水凝胶材料。S3. Pour the precursor solution in S2 on a polytetrafluoroethylene plate and press another polytetrafluoroethylene plate on it, and use ultraviolet light to irradiate the precursor solution through the polytetrafluoroethylene plate , initiate free radical polymerization to make it gel, and obtain PEG-type polythiourethane-acrylic acid composite hydrogel material.
在上述技术方案的基础上,本发明还可以有如下进一步的具体选择或最优选择。On the basis of the above technical solutions, the present invention may also have the following further specific options or optimal options.
优选的,步骤S1中的二巯基乙酸聚乙烯醇酯单体为二巯基乙酸PEG200酯、二巯基乙酸PEG400酯、二巯基乙酸PEG600酯、二巯基乙酸PEG800酯、二巯基乙酸PEG1000和二巯基乙酸PEG1500酯中的任一种。Preferably, the polyvinyl alcohol dimercaptoacetic acid monomer in step S1 is PEG200 dimercaptoacetic acid, PEG400 dimercaptoacetic acid, PEG600 dimercaptoacetic acid, PEG800 dimercaptoacetic acid, PEG1000 dimercaptoacetic acid and PEG1500 dimercaptoacetic acid any of the esters.
上述二巯基乙酸聚乙烯醇酯的化学结构类似于二巯基乙酸乙二醇酯,其可由以下方法制备:将巯基乙酸、聚乙二醇、甲基苯磺酸及DTT加入带油水分离器的三口烧瓶中,并加入甲苯作带水剂,氮气保护下升温至125-130℃反应8-10h,反应完成后,萃取、分液、洗涤、除水、旋蒸、真空干燥即得二巯基乙酸聚乙烯醇酯,其中巯基乙酸与聚乙二醇的摩尔比为2.05-2.15:1(巯基乙酸过量,保证巯基封端),甲基苯磺酸与聚乙二醇的摩尔比为1-1.5:100,DTT与聚乙二醇的摩尔比为4.1-5.5:100,带水剂甲苯与聚乙二醇的用量比例为50-200mL:10-20g。聚乙二醇为PEG200、PEG400、PEG600、PEG800、PEG1000或PEG1500中,反应生成的产物相应的为二巯基乙酸PEG200酯、二巯基乙酸PEG400酯、二巯基乙酸PEG600酯、二巯基乙酸PEG800酯、二巯基乙酸PEG1000和二巯基乙酸PEG1500酯。The chemical structure of the above-mentioned polyvinyl dimercaptoacetate is similar to ethylene glycol dimercaptoacetate, and it can be prepared by the following method: adding thioglycolic acid, polyethylene glycol, toluenesulfonic acid and DTT to the three ports of the oil-water separator In the flask, add toluene as a water-carrying agent, raise the temperature to 125-130°C under nitrogen protection, and react for 8-10h. After the reaction is completed, extract, separate, wash, remove water, rotary evaporate, and vacuum dry to obtain dimercaptoacetic acid polymer Vinyl alcohol ester, wherein the molar ratio of thioglycolic acid to polyethylene glycol is 2.05-2.15:1 (excessive amount of thioglycolic acid ensures capping of mercapto groups), and the molar ratio of toluenesulfonic acid to polyethylene glycol is 1-1.5: 100, the molar ratio of DTT to polyethylene glycol is 4.1-5.5:100, and the dosage ratio of water-carrying agent toluene to polyethylene glycol is 50-200mL:10-20g. Polyethylene glycol is PEG200, PEG400, PEG600, PEG800, PEG1000 or PEG1500, and the products generated by the reaction are correspondingly PEG200 dimercaptoacetic acid, PEG400 dimercaptoacetic acid, PEG600 dimercaptoacetic acid, PEG800 dimercaptoacetic acid, PEG1000 Thioglycolate and PEG1500 Dithioglycolate.
优选的,步骤S1中的二异氰酸酯类单体为MDI、HDI、TDI、XDI和IPDI中的任一种。Preferably, the diisocyanate monomer in step S1 is any one of MDI, HDI, TDI, XDI and IPDI.
具体的,步骤S1中的二异氰酸酯类单体、二巯基乙酸聚乙烯醇酯单体及HEMA的摩尔比为(2.5-4):2:(1-4),步骤S1中DMF溶剂的质量为所述二巯基乙酸聚乙烯醇酯单体、二异氰酸酯类单体及HEMA总质量的2.3-19倍。Specifically, the molar ratio of the diisocyanate monomer, polyvinyl dimercaptoacetate monomer and HEMA in step S1 is (2.5-4): 2: (1-4), and the quality of the DMF solvent in step S1 is The total mass of the polyvinyl alcohol dimercaptoacetate monomer, diisocyanate monomer and HEMA is 2.3-19 times.
具体的,步骤S1中双键封端的PEG型聚硫氨酯的制备过程中,首先按比例计算各物质的用量,将计算量的二巯基乙酸聚乙烯醇酯单体与计算量一半的DMF溶剂加入反应容器内,将计算量的二异氰酸酯类单体与计算量一半的DMF溶剂混合并采用滴加方式加入所述反应容器内,氩气保护下升温至30-80℃,搅拌进行聚合反应得PEG型聚硫氨酯,反应完成后加入计算量的HEMA,氩气保护下升温至30-80℃,搅拌反应2-7h进行双键封端,透析袋透析去除未反应的小分子单体,离心、干燥,即得双键封端的PEG型聚硫氨酯。Specifically, in the preparation process of the double-bond-terminated PEG-type polythiourethane in step S1, first calculate the amount of each substance in proportion, and mix the calculated amount of polyvinyl alcohol dimercaptoacetate monomer with half of the calculated amount of DMF solvent Put into the reaction vessel, mix the calculated amount of diisocyanate monomer with half of the calculated amount of DMF solvent and add it dropwise into the reaction vessel, raise the temperature to 30-80°C under the protection of argon, stir and carry out polymerization reaction to obtain PEG-type polythiourethane, after the reaction is completed, add the calculated amount of HEMA, raise the temperature to 30-80°C under the protection of argon, stir the reaction for 2-7 hours to seal the double bond, and dialysis the dialysis bag to remove unreacted small molecular monomers. After centrifugation and drying, the double bond-terminated PEG type polythiourethane is obtained.
具体的,步骤S2中丙烯酸与双键封端的PEG型聚硫氨酯的质量比为0.54-2.33,步骤S2中的DMF的质量为所述丙烯酸与双键封端的PEG型聚硫氨酯总质量的1.5-4倍。Specifically, in step S2, the mass ratio of acrylic acid to double-bond-terminated PEG-type polythiourethane is 0.54-2.33, and the quality of DMF in step S2 is the total mass of the acrylic acid and double-bond-terminated PEG-type polythiourethane 1.5-4 times.
具体的,步骤S2中的光引发剂及交联剂的质量均为所述丙烯酸与双键封端的PEG型聚硫氨酯总质量的0.85-1.25%,所述光引发剂为Darocur 1173,所述交联剂为TEGDMA。Specifically, the quality of the photoinitiator and crosslinking agent in step S2 is 0.85-1.25% of the total mass of the acrylic acid and double bond-terminated PEG type polythiourethane, and the photoinitiator is Darocur 1173, so The cross-linking agent is TEGDMA.
具体的,步骤S3中两块聚四氟乙烯板之间形成的前驱体溶液液膜厚度为20-200μm。Specifically, the thickness of the liquid film of the precursor solution formed between the two polytetrafluoroethylene plates in step S3 is 20-200 μm.
本发明还要求保护一种PEG型聚硫氨酯-丙烯酸复合水凝胶材料,其通过上述方法制备。The present invention also claims a PEG type polythiourethane-acrylic acid composite hydrogel material, which is prepared by the above method.
本发明还要求保护上述PEG型聚硫氨酯-丙烯酸复合水凝胶材料在用作软质隐形眼镜的镜体材料或人工眼角膜的植入材料方面的应用。The present invention also claims to protect the application of the above-mentioned PEG type polythiourethane-acrylic acid composite hydrogel material as a lens body material of a soft contact lens or an implant material of an artificial cornea.
与现有技术相比,本发明的有益效果是:Compared with prior art, the beneficial effect of the present invention is:
1、通过本发明制备方法制得的复合水凝胶材料的折射率比人眼角膜的还要高,平衡水含量和人眼角膜相近,且具有很好的生物相容性,在人工眼角膜及角膜接触镜方面有很好的应用前景;1. The refractive index of the composite hydrogel material prepared by the preparation method of the present invention is higher than that of the human cornea, the equilibrium water content is similar to that of the human cornea, and has good biocompatibility. And contact lenses have a good application prospect;
2、通过本发明制备方法制得的复合水凝胶材料清澈而透明,测得其折射率在干燥状态下高达1.558,在平衡含水状态下高达1.467,同时所制备的水凝胶平衡含水量最高能达到85%,其为纯聚合物水凝胶体系,其较高的折射率相对于现有技术而言是一个比较大的进步;2. The composite hydrogel material prepared by the preparation method of the present invention is clear and transparent, and the measured refractive index is as high as 1.558 in the dry state and 1.467 in the equilibrium water state, and the prepared hydrogel has the highest equilibrium water content It can reach 85%, which is a pure polymer hydrogel system, and its higher refractive index is a relatively big improvement compared with the prior art;
3、本发明提供的复合水凝胶材料利用氢键的作用将水凝胶中的自由水固定起来,从而有效提高了该材料的折射率;3. The composite hydrogel material provided by the present invention uses hydrogen bonds to fix the free water in the hydrogel, thereby effectively improving the refractive index of the material;
4、本发明使用一系列的PEG型聚硫氨酯为制备复合水凝胶材料的原料,随着PEG分子量的增大,最终得到的复合水凝胶材料的氢键作用也随之变化,能对折射率和含水量进行一定的调控;4. The present invention uses a series of PEG-type polythiourethanes as raw materials for preparing composite hydrogel materials. As the molecular weight of PEG increases, the hydrogen bonding of the composite hydrogel materials that are finally obtained also changes. Adjust the refractive index and water content;
5、本发明设计出的PEG型聚硫氨酯,可以通过不同芳环、脂肪结构的异氰酸以及通过改变分子链中软硬段的组成来对水凝胶的折射率和含水量进行一定的调控;5. The PEG-type polythiourethane designed by the present invention can be used to determine the refractive index and water content of the hydrogel through isocyanic acid with different aromatic rings and aliphatic structures and by changing the composition of soft and hard segments in the molecular chain. regulation;
6、制备本发明的水凝胶材料所用的原料来源广、价廉,有利于降低成本。6. The raw materials used to prepare the hydrogel material of the present invention have wide sources and are cheap, which is beneficial to reduce costs.
附图说明Description of drawings
图1为本发明提供的一种PEG型聚硫氨酯-丙烯酸复合水凝胶材料的原料双键封端的PEG型聚硫氨酯的合成路线图。Fig. 1 is a synthetic route diagram of a PEG type polythiourethane-acrylic acid composite hydrogel material provided by the present invention with double bond-terminated raw materials.
具体实施方式detailed description
以下结合附图对本发明的原理和特征进行描述,所举实例只用于解释本发明,并非用于限定本发明的范围。The principles and features of the present invention are described below in conjunction with the accompanying drawings, and the examples given are only used to explain the present invention, and are not intended to limit the scope of the present invention.
本发明的下述实施例中采用的方法未作特别说明均为常规方法,所用药品未作特别说明均为市售产品。下述实施例中制备PEG型聚硫氨酯-丙烯酸复合水凝胶材料的原料双键封端的PEG型聚硫氨酯时的合成路线如图1所示。The methods adopted in the following examples of the present invention are conventional methods unless otherwise specified, and the medicines used are all commercially available products unless otherwise specified. In the following examples, the synthetic route for preparing PEG-type polythiourethane-acrylic acid composite hydrogel material double-bond-terminated PEG-type polythiourethane is shown in FIG. 1 .
实施例1Example 1
一种PEG型聚硫氨酯-丙烯酸复合水凝胶材料的制备方法,包括如下步骤:A preparation method of PEG type polythiourethane-acrylic acid composite hydrogel material, comprising the steps:
S1.按照MDI、二巯基乙酸PEG200酯和HEMA摩尔比3:2:2、三者总质量1g及三者溶于DMF溶剂后固含量为12.8%(DMF溶剂为三种溶质总质量的6.8倍)的要求,计算各原料及溶剂的用量,将计算量的二巯基乙酸PEG200酯和3.4g DMF加入三口烧瓶,计算量的MDI和3.4gDMF采用滴加的方式加入,在氩气、搅拌和温度为30℃条件下反应5h,反应5h后,加入计算量的HEMA,在氩气、搅拌和温度为80℃条件下反应2h,保证双键封端,采用分子量500的透析袋透析5天除去未反应的小分子单体,其中前面两天采用1:1的乙醇水溶液,后面改为纯水,每隔10h换一次水,最后离心,50℃真空干燥箱干燥,得到白色粉末状的双键封端的PEG型聚硫氨酯;S1. According to MDI, PEG200 dimercaptoacetic acid ester and HEMA molar ratio 3:2:2, the total mass of the three is 1g and the solid content after the three are dissolved in DMF solvent is 12.8% (DMF solvent is 6.8 times the total mass of the three solutes ), calculate the consumption of each raw material and solvent, add the three-necked flask with the calculated amount of dimercaptoacetic acid PEG200 ester and 3.4g DMF, the calculated amount of MDI and the 3.4gDMF are added dropwise, under argon, stirring and temperature React for 5 hours at 30°C. After 5 hours of reaction, add the calculated amount of HEMA, and react for 2 hours under argon gas, stirring, and temperature at 80°C to ensure that the double bonds are terminated. Use a dialysis bag with a molecular weight of 500 for 5 days to remove unresolved impurities. For the small molecular monomers to be reacted, a 1:1 ethanol aqueous solution was used for the first two days, followed by pure water, and the water was changed every 10 hours. Finally, it was centrifuged and dried in a vacuum oven at 50°C to obtain a white powdery double bond sealant. PEG-type polythiourethane at the end;
S2.取0.5g步骤S1制得的双键封端的PEG型聚硫氨酯、0.5g丙烯酸单体溶于1.5gDMF中,首次超声处理(40-100w、20-40kHz)10-30min得混合液,向所述混合液中加入10mg光引发剂Darocur 1173和10mg交联剂TEGDMA,再次超声处理(40-100w、20-40kHz)20-120s,使之成为透明的前驱体溶液;S2. Take 0.5g of the double-bond-terminated PEG-type polythiourethane prepared in step S1 and 0.5g of acrylic monomer dissolved in 1.5g of DMF, and first ultrasonic treatment (40-100w, 20-40kHz) for 10-30min to obtain a mixed solution 10 mg of photoinitiator Darocur 1173 and 10 mg of crosslinker TEGDMA were added to the mixed solution, and ultrasonic treatment (40-100w, 20-40kHz) was performed for 20-120s again to make it a transparent precursor solution;
S3.将S2中的前驱体溶液倒在一块聚四氟乙烯板上并在其上压上另一块聚四氟乙烯板,使用300-400nm紫外光透过所述聚四氟乙烯板照射所述前驱体溶液1-2h,引发自由基聚合使其凝胶化,即得PEG型聚硫氨酯-丙烯酸复合水凝胶材料。S3. Pour the precursor solution in S2 onto a polytetrafluoroethylene plate and press another polytetrafluoroethylene plate on it, and use 300-400nm ultraviolet light to irradiate the polytetrafluoroethylene plate through the polytetrafluoroethylene plate. Precursor solution for 1-2 hours, initiate free radical polymerization to make it gel, and obtain PEG type polythiourethane-acrylic acid composite hydrogel material.
实施例2Example 2
一种PEG型聚硫氨酯-丙烯酸复合水凝胶材料的制备方法,包括如下步骤:A preparation method of PEG type polythiourethane-acrylic acid composite hydrogel material, comprising the steps:
S1.按照MDI、二巯基乙酸PEG400酯和HEMA摩尔比2.5:2.0:1.0、三者总质量1g及三者溶于DMF溶剂后固含量为10%(DMF溶剂为三种溶质总质量的9倍)的要求,计算各原料及溶剂的用量,将计算量的二巯基乙酸PEG400酯和4.5g DMF加入三口烧瓶,计算量的MDI和4.5g DMF采用滴加的方式加入,在氩气、搅拌和温度为65℃条件下反应3h,反应3h后,加入计算量的HEMA,在氩气、搅拌和温度为60℃条件下反应4h,保证双键封端,采用分子量500的透析袋透析5天除去未反应的小分子单体,其中前面两天采用1:1的乙醇水溶液,后面改为纯水,每隔10h换一次水,最后离心,50℃真空干燥箱干燥,得到白色粉末状的双键封端的PEG型聚硫氨酯;S1. According to MDI, PEG400 dimercaptoacetic acid ester and HEMA molar ratio 2.5:2.0:1.0, the total mass of the three is 1g and the solid content after the three are dissolved in DMF solvent is 10% (DMF solvent is 9 times the total mass of the three solutes ), calculate the consumption of each raw material and solvent, add the three-necked flask with the calculated amount of dimercaptoacetic acid PEG400 ester and 4.5g DMF, the calculated amount of MDI and the 4.5g DMF are added dropwise, under argon, stirring and React for 3 hours at a temperature of 65°C. After 3 hours of reaction, add the calculated amount of HEMA, and react for 4 hours under argon gas, stirring, and a temperature of 60°C to ensure that the double bonds are terminated, and use a dialysis bag with a molecular weight of 500 for 5 days to remove For unreacted small molecular monomers, use 1:1 ethanol aqueous solution for the first two days, then change to pure water, change the water every 10 hours, and finally centrifuge and dry in a vacuum oven at 50°C to obtain a white powdery double bond End-blocked PEG type polythiourethane;
S2.取0.33g步骤S1制得的双键封端的PEG型聚硫氨酯、0.66g丙烯酸单体溶于2.97g DMF中,首次超声处理(40-100w、20-40kHz)10-30min得混合液,向所述混合液中加入8.8mg光引发剂Darocur 1173和8.8mg交联剂TEGDMA,再次超声处理(40-100w、20-40kHz)20-120s,使之成为透明的前驱体溶液;S2. Take 0.33g of the double bond-terminated PEG-type polythiourethane prepared in step S1 and 0.66g of acrylic monomer dissolved in 2.97g of DMF, and first ultrasonic treatment (40-100w, 20-40kHz) for 10-30min to get mixed solution, add 8.8mg of photoinitiator Darocur 1173 and 8.8mg of crosslinking agent TEGDMA to the mixed solution, and then ultrasonically treat (40-100w, 20-40kHz) for 20-120s to make it a transparent precursor solution;
S3.将S2中的前驱体溶液倒在一块聚四氟乙烯板上并在其上压上另一块聚四氟乙烯板,使用300-400nm紫外光透过所述聚四氟乙烯板照射所述前驱体溶液1-2h,引发自由基聚合使其凝胶化,即得PEG型聚硫氨酯-丙烯酸复合水凝胶材料。S3. Pour the precursor solution in S2 onto a polytetrafluoroethylene plate and press another polytetrafluoroethylene plate on it, and use 300-400nm ultraviolet light to irradiate the polytetrafluoroethylene plate through the polytetrafluoroethylene plate. Precursor solution for 1-2 hours, initiate free radical polymerization to make it gel, and obtain PEG type polythiourethane-acrylic acid composite hydrogel material.
实施例3Example 3
一种PEG型聚硫氨酯-丙烯酸复合水凝胶材料的制备方法,包括如下步骤:A preparation method of PEG type polythiourethane-acrylic acid composite hydrogel material, comprising the steps:
S1.按照TDI、二巯基乙酸PEG200酯和HEMA摩尔比3.5:2.0:3.0、三者总质量1g及三者溶于DMF溶剂后固含量为20%(DMF溶剂为三种溶质总质量的4倍)的要求,计算各原料及溶剂的用量,将计算量的二巯基乙酸PEG200酯和2g DMF加入三口烧瓶,计算量的TDI和2gDMF采用滴加的方式加入,在氩气、搅拌和温度为80℃条件下反应2h,反应2h后,加入计算量的HEMA,在氩气、搅拌和温度为50℃条件下反应3h,保证双键封端,采用分子量500的透析袋透析5天除去未反应的小分子单体,其中前面两天采用1:1的乙醇水溶液,后面改为纯水,每隔10h换一次水,最后离心,50℃真空干燥箱干燥,得到白色粉末状的双键封端的PEG型聚硫氨酯;S1. According to TDI, PEG200 dimercaptoacetic acid ester and HEMA molar ratio 3.5:2.0:3.0, the total mass of the three is 1g and the solid content after the three are dissolved in DMF solvent is 20% (DMF solvent is 4 times of the total mass of the three solutes ), calculate the consumption of each raw material and solvent, add the three-necked flask with the calculated amount of dimercaptoacetic acid PEG200 ester and 2g DMF, and add the TDI and 2gDMF of the calculated amount by adding dropwise, under argon, stirring and a temperature of 80 React for 2 hours at ℃. After 2 hours of reaction, add the calculated amount of HEMA, and react for 3 hours under argon, stirring and temperature at 50℃ to ensure that the double bonds are terminated. Use a dialysis bag with a molecular weight of 500 for 5 days to remove unreacted For small molecular monomers, 1:1 ethanol aqueous solution was used for the first two days, followed by pure water, and the water was changed every 10 hours. Finally, it was centrifuged and dried in a vacuum oven at 50°C to obtain white powdery double bond-terminated PEG. Type polythiourethane;
S2.取0.4g步骤S1制得的双键封端的PEG型聚硫氨酯、0.6g丙烯酸单体溶于4g DMF中,首次超声处理(40-100w、20-40kHz)10-30min得混合液,向所述混合液中加入12.5mg光引发剂Darocur 1173和12.5mg交联剂TEGDMA,再次超声处理(40-100w、20-40kHz)20-120s,使之成为透明的前驱体溶液;S2. Take 0.4g of the double-bond-terminated PEG-type polythiourethane prepared in step S1 and 0.6g of acrylic monomer dissolved in 4g of DMF, and first ultrasonic treatment (40-100w, 20-40kHz) for 10-30min to obtain a mixed solution 12.5mg of photoinitiator Darocur 1173 and 12.5mg of crosslinker TEGDMA were added to the mixed solution, and ultrasonic treatment (40-100w, 20-40kHz) was performed for 20-120s again to make it a transparent precursor solution;
S3.将S2中的前驱体溶液倒在一块聚四氟乙烯板上并在其上压上另一块聚四氟乙烯板,使用250-380nm紫外光透过所述聚四氟乙烯板照射所述前驱体溶液1-2h,引发自由基聚合使其凝胶化,即得PEG型聚硫氨酯-丙烯酸复合水凝胶材料。S3. Pour the precursor solution in S2 onto a polytetrafluoroethylene plate and press another polytetrafluoroethylene plate on it, and use 250-380nm ultraviolet light to irradiate the polytetrafluoroethylene plate through the polytetrafluoroethylene plate. Precursor solution for 1-2 hours, initiate free radical polymerization to make it gel, and obtain PEG type polythiourethane-acrylic acid composite hydrogel material.
实施例4Example 4
一种PEG型聚硫氨酯-丙烯酸复合水凝胶材料的制备方法,包括如下步骤:A preparation method of PEG type polythiourethane-acrylic acid composite hydrogel material, comprising the steps:
S1.按照TDI、二巯基乙酸PEG400酯和HEMA摩尔比4.0:2.0:4.0、三者总质量1g及三者溶于DMF溶剂后固含量为12.8%(DMF溶剂为三种溶质总质量的6.8倍)的要求,计算各原料及溶剂的用量,将计算量的二巯基乙酸PEG400酯和3.4g DMF加入三口烧瓶,计算量的TDI和3.4g DMF采用滴加的方式加入,在氩气、搅拌和温度为80℃条件下反应2h,反应2h后,加入计算量的HEMA,在氩气、搅拌和温度为30℃条件下反应7h,保证双键封端,采用分子量500的透析袋透析5天除去未反应的小分子单体,其中前面两天采用1:1的乙醇水溶液,后面改为纯水,每隔10h换一次水,最后离心,50℃真空干燥箱干燥,得到白色粉末状的双键封端的PEG型聚硫氨酯;S1. According to TDI, PEG400 dimercaptoacetic acid ester and HEMA molar ratio 4.0:2.0:4.0, the total mass of the three is 1g and the solid content after the three are dissolved in DMF solvent is 12.8% (DMF solvent is 6.8 times of the total mass of the three solutes ), calculate the consumption of each raw material and solvent, add the three-necked flask with the calculated amount of dimercaptoacetic acid PEG400 ester and 3.4g DMF, the TDI and the 3.4g DMF of the calculated amount are added dropwise, under argon, stirring and React for 2 hours at a temperature of 80°C. After 2 hours of reaction, add the calculated amount of HEMA, and react for 7 hours under argon gas, stirring, and a temperature of 30°C to ensure that the double bonds are terminated. Use a dialysis bag with a molecular weight of 500 for 5 days to remove For unreacted small molecular monomers, use 1:1 ethanol aqueous solution for the first two days, then change to pure water, change the water every 10 hours, and finally centrifuge and dry in a vacuum oven at 50°C to obtain a white powdery double bond End-blocked PEG type polythiourethane;
S2.取0.29g步骤S1制得的双键封端的PEG型聚硫氨酯、0.71g丙烯酸单体溶于3.5gDMF中,首次超声处理(40-100w、20-40kHz)10-30min得混合液,向所述混合液中加入9.4mg光引发剂Darocur 1173和11.2mg交联剂TEGDMA,再次超声处理(40-100w、20-40kHz)20-120s,使之成为透明的前驱体溶液;S2. Take 0.29g of the double-bond-terminated PEG-type polythiourethane prepared in step S1, and dissolve 0.71g of acrylic acid monomer in 3.5g of DMF, and perform the first ultrasonic treatment (40-100w, 20-40kHz) for 10-30min to obtain a mixed solution , add 9.4mg of photoinitiator Darocur 1173 and 11.2mg of crosslinking agent TEGDMA to the mixed solution, and ultrasonicate again (40-100w, 20-40kHz) for 20-120s to make it a transparent precursor solution;
S3.将S2中的前驱体溶液倒在一块聚四氟乙烯板上并在其上压上另一块聚四氟乙烯板,使用300-400nm紫外光透过所述聚四氟乙烯板照射所述前驱体溶液1-2h,引发自由基聚合使其凝胶化,即得PEG型聚硫氨酯-丙烯酸复合水凝胶材料。S3. Pour the precursor solution in S2 onto a polytetrafluoroethylene plate and press another polytetrafluoroethylene plate on it, and use 300-400nm ultraviolet light to irradiate the polytetrafluoroethylene plate through the polytetrafluoroethylene plate. Precursor solution for 1-2 hours, initiate free radical polymerization to make it gel, and obtain PEG type polythiourethane-acrylic acid composite hydrogel material.
实施例5Example 5
一种PEG型聚硫氨酯-丙烯酸复合水凝胶材料的制备方法,包括如下步骤:A preparation method of PEG type polythiourethane-acrylic acid composite hydrogel material, comprising the steps:
S1.按照IPDI、二巯基乙酸PEG200酯和HEMA摩尔比3.5:2:3.0、三者总质量1g及三者溶于DMF溶剂后固含量为12.8%(DMF溶剂为三种溶质总质量的6.8倍)的要求,计算各原料及溶剂的用量,将计算量的二巯基乙酸PEG200酯和3.4g DMF加入三口烧瓶,计算量的IPDI和3.4g DMF采用滴加的方式加入,在氩气、搅拌和温度为50℃条件下反应4h,反应4h后,加入计算量的HEMA,在氩气、搅拌和温度为80℃条件下反应2h,保证双键封端,采用分子量500的透析袋透析5天除去未反应的小分子单体,其中前面两天采用1:1的乙醇水溶液,后面改为纯水,每隔10h换一次水,最后离心,50℃真空干燥箱干燥,得到白色粉末状的双键封端的PEG型聚硫氨酯;S1. According to IPDI, PEG200 dimercaptoacetic acid ester and HEMA molar ratio 3.5:2:3.0, the total mass of the three is 1g and the solid content after the three are dissolved in DMF solvent is 12.8% (DMF solvent is 6.8 times the total mass of the three solutes ), calculate the consumption of each raw material and solvent, add the three-necked flask with the calculated amount of dimercaptoacetic acid PEG200 ester and 3.4g DMF, the calculated amount of IPDI and the 3.4g DMF adopt the mode of adding dropwise, under argon, stirring and React for 4 hours at a temperature of 50°C. After 4 hours of reaction, add the calculated amount of HEMA, and react for 2 hours under argon gas, stirring, and a temperature of 80°C to ensure that the double bonds are terminated. Use a dialysis bag with a molecular weight of 500 for 5 days to remove For unreacted small molecular monomers, use 1:1 ethanol aqueous solution for the first two days, then change to pure water, change the water every 10 hours, and finally centrifuge and dry in a vacuum oven at 50°C to obtain a white powdery double bond End-blocked PEG type polythiourethane;
S2.取0.5g步骤S1制得的双键封端的PEG型聚硫氨酯、0.5g丙烯酸单体溶于1.4gDMF中,首次超声处理(40-100w、20-40kHz)10-30min得混合液,向所述混合液中加入9.5mg光引发剂Darocur 1173和8.5mg交联剂TEGDMA,再次超声处理(40-100w、20-40kHz)20-120s,使之成为透明的前驱体溶液;S2. Take 0.5g of the double-bond-terminated PEG-type polythiourethane prepared in step S1 and 0.5g of acrylic monomer dissolved in 1.4g of DMF, and first ultrasonic treatment (40-100w, 20-40kHz) for 10-30min to obtain a mixed solution , add 9.5mg of photoinitiator Darocur 1173 and 8.5mg of crosslinking agent TEGDMA to the mixed solution, and ultrasonicate again (40-100w, 20-40kHz) for 20-120s to make it a transparent precursor solution;
S3.将S2中的前驱体溶液倒在一块聚四氟乙烯板上并在其上压上另一块聚四氟乙烯板,使用300-400nm紫外光透过所述聚四氟乙烯板照射所述前驱体溶液1-2h,引发自由基聚合使其凝胶化,即得PEG型聚硫氨酯-丙烯酸复合水凝胶材料。S3. Pour the precursor solution in S2 onto a polytetrafluoroethylene plate and press another polytetrafluoroethylene plate on it, and use 300-400nm ultraviolet light to irradiate the polytetrafluoroethylene plate through the polytetrafluoroethylene plate. Precursor solution for 1-2 hours, initiate free radical polymerization to make it gel, and obtain PEG type polythiourethane-acrylic acid composite hydrogel material.
实施例6Example 6
一种PEG型聚硫氨酯-丙烯酸复合水凝胶材料的制备方法,包括如下步骤:A preparation method of PEG type polythiourethane-acrylic acid composite hydrogel material, comprising the steps:
S1.按照IPDI、二巯基乙酸PEG600酯和HEMA摩尔比2.5:2:1、三者总质量1g及三者溶于DMF溶剂后固含量为12.8%(DMF溶剂为三种溶质总质量的2.3倍)的要求,计算各原料及溶剂的用量,将计算量的二巯基乙酸PEG600酯和1.15g DMF加入三口烧瓶,计算量的IPDI和1.15g DMF采用滴加的方式加入,在氩气、搅拌和温度为75℃条件下反应2h,反应2h后,加入计算量的HEMA,在氩气、搅拌和温度为75℃条件下反应2h,保证双键封端,采用分子量500的透析袋透析5天除去未反应的小分子单体,其中前面两天采用1:1的乙醇水溶液,后面改为纯水,每隔10h换一次水,最后离心,50℃真空干燥箱干燥,得到白色粉末状的双键封端的PEG型聚硫氨酯;S1. According to IPDI, PEG600 dimercaptoacetic acid ester and HEMA molar ratio 2.5:2:1, the total mass of the three is 1g and the solid content after the three are dissolved in DMF solvent is 12.8% (DMF solvent is 2.3 times the total mass of the three solutes ), calculate the consumption of each raw material and solvent, add the three-necked flask with the calculated amount of dimercaptoacetic acid PEG600 ester and 1.15g DMF, the IPDI of the calculated amount and the 1.15g DMF adopt the mode of adding dropwise, under argon, stirring and React for 2 hours at a temperature of 75°C. After 2 hours of reaction, add the calculated amount of HEMA, and react for 2 hours under argon gas, stirring, and a temperature of 75°C to ensure that the double bonds are terminated. Use a dialysis bag with a molecular weight of 500 for 5 days to remove For unreacted small molecular monomers, use 1:1 ethanol aqueous solution for the first two days, then change to pure water, change the water every 10 hours, and finally centrifuge and dry in a vacuum oven at 50°C to obtain a white powdery double bond End-blocked PEG type polythiourethane;
S2.取0.5g步骤S1制得的双键封端的PEG型聚硫氨酯、0.5g丙烯酸单体溶于2.5gDMF中,首次超声处理(40-100w、20-40kHz)10-30min得混合液,向所述混合液中加入10mg光引发剂Darocur 1173和10mg交联剂TEGDMA,再次超声处理(40-100w、20-40kHz)20-120s,使之成为透明的前驱体溶液;S2. Take 0.5g of the double-bond-terminated PEG-type polythiourethane prepared in step S1 and 0.5g of acrylic monomer dissolved in 2.5g of DMF, and first ultrasonic treatment (40-100w, 20-40kHz) for 10-30min to obtain a mixed solution 10 mg of photoinitiator Darocur 1173 and 10 mg of crosslinker TEGDMA were added to the mixed solution, and ultrasonic treatment (40-100w, 20-40kHz) was performed for 20-120s again to make it a transparent precursor solution;
S3.将S2中的前驱体溶液倒在一块聚四氟乙烯板上并在其上压上另一块聚四氟乙烯板,使用300-400nm紫外光透过所述聚四氟乙烯板照射所述前驱体溶液1-2h,引发自由基聚合使其凝胶化,即得PEG型聚硫氨酯-丙烯酸复合水凝胶材料。S3. Pour the precursor solution in S2 onto a polytetrafluoroethylene plate and press another polytetrafluoroethylene plate on it, and use 300-400nm ultraviolet light to irradiate the polytetrafluoroethylene plate through the polytetrafluoroethylene plate. Precursor solution for 1-2 hours, initiate free radical polymerization to make it gel, and obtain PEG type polythiourethane-acrylic acid composite hydrogel material.
实施例7Example 7
一种PEG型聚硫氨酯-丙烯酸复合水凝胶材料的制备方法,包括如下步骤:A preparation method of PEG type polythiourethane-acrylic acid composite hydrogel material, comprising the steps:
S1.按照HDI、二巯基乙酸PEG800酯和HEMA摩尔比2.5:2:1、三者总质量1g及三者溶于DMF溶剂后固含量为12.8%(DMF溶剂为三种溶质总质量的2.3倍)的要求,计算各原料及溶剂的用量,将计算量的二巯基乙酸PEG800酯和1.15g DMF加入三口烧瓶,计算量的HDI和1.15g DMF采用滴加的方式加入,在氩气、搅拌和温度为80℃条件下反应2h,反应2h后,加入计算量的HEMA,在氩气、搅拌和温度为80℃条件下反应2h,保证双键封端,采用分子量500的透析袋透析5天除去未反应的小分子单体,其中前面两天采用1:1的乙醇水溶液,后面改为纯水,每隔10h换一次水,最后离心,50℃真空干燥箱干燥,得到白色粉末状的双键封端的PEG型聚硫氨酯;S1. According to HDI, PEG800 dimercaptoacetic acid ester and HEMA molar ratio 2.5:2:1, the total mass of the three is 1g and the solid content after the three are dissolved in DMF solvent is 12.8% (DMF solvent is 2.3 times the total mass of the three solutes ) requirements, calculate the consumption of each raw material and solvent, add the three-necked flask of the calculated amount of dimercaptoacetic acid PEG800 ester and 1.15g DMF, the calculated amount of HDI and the 1.15g DMF are added dropwise, under argon, stirring and React for 2 hours at a temperature of 80°C. After 2 hours of reaction, add the calculated amount of HEMA, and react for 2 hours under argon gas, stirring, and a temperature of 80°C to ensure that the double bonds are terminated. Use a dialysis bag with a molecular weight of 500 for 5 days to remove For unreacted small molecular monomers, use 1:1 ethanol aqueous solution for the first two days, then change to pure water, change the water every 10 hours, and finally centrifuge and dry in a vacuum oven at 50°C to obtain a white powdery double bond End-blocked PEG type polythiourethane;
S2.取0.5g步骤S1制得的双键封端的PEG型聚硫氨酯、0.5g丙烯酸单体溶于2.5gDMF中,首次超声处理(40-100w、20-40kHz)10-30min得混合液,向所述混合液中加入10mg光引发剂Darocur 1173和10mg交联剂TEGDMA,再次超声处理(40-100w、20-40kHz)20-120s,使之成为透明的前驱体溶液;S2. Take 0.5g of the double-bond-terminated PEG-type polythiourethane prepared in step S1 and 0.5g of acrylic monomer dissolved in 2.5g of DMF, and first ultrasonic treatment (40-100w, 20-40kHz) for 10-30min to obtain a mixed solution 10 mg of photoinitiator Darocur 1173 and 10 mg of crosslinker TEGDMA were added to the mixed solution, and ultrasonic treatment (40-100w, 20-40kHz) was performed for 20-120s again to make it a transparent precursor solution;
S3.将S2中的前驱体溶液倒在一块聚四氟乙烯板上并在其上压上另一块聚四氟乙烯板,使用300-400nm紫外光透过所述聚四氟乙烯板照射所述前驱体溶液1-2h,引发自由基聚合使其凝胶化,即得PEG型聚硫氨酯-丙烯酸复合水凝胶材料。S3. Pour the precursor solution in S2 onto a polytetrafluoroethylene plate and press another polytetrafluoroethylene plate on it, and use 300-400nm ultraviolet light to irradiate the polytetrafluoroethylene plate through the polytetrafluoroethylene plate. Precursor solution for 1-2 hours, initiate free radical polymerization to make it gel, and obtain PEG type polythiourethane-acrylic acid composite hydrogel material.
实施例8Example 8
一种PEG型聚硫氨酯-丙烯酸复合水凝胶材料的制备方法,包括如下步骤:A preparation method of PEG type polythiourethane-acrylic acid composite hydrogel material, comprising the steps:
S1.按照XDI、二巯基乙酸PEG1000酯和HEMA摩尔比3.0:2.0:2.0、三者总质量1g及三者溶于DMF溶剂后固含量为12.8%(DMF溶剂为三种溶质总质量的6.8倍)的要求,计算各原料及溶剂的用量,将计算量的二巯基乙酸PEG1000酯和3.4g DMF加入三口烧瓶,计算量的XDI和3.4g DMF采用滴加的方式加入,在氩气、搅拌和温度为80℃条件下反应2h,反应2h后,加入计算量的HEMA,在氩气、搅拌和温度为80℃条件下反应2h,保证双键封端,采用分子量500的透析袋透析5天除去未反应的小分子单体,其中前面两天采用1:1的乙醇水溶液,后面改为纯水,每隔10h换一次水,最后离心,50℃真空干燥箱干燥,得到白色粉末状的双键封端的PEG型聚硫氨酯;S1. According to XDI, the molar ratio of PEG1000 dimercaptoacetic acid and HEMA is 3.0:2.0:2.0, the total mass of the three is 1g, and the solid content after the three are dissolved in DMF solvent is 12.8% (DMF solvent is 6.8 times the total mass of the three solutes ), calculate the consumption of each raw material and solvent, add the three-necked flask with the calculated amount of dimercaptoacetic acid PEG1000 ester and 3.4g DMF, the calculated amount of XDI and the 3.4g DMF are added dropwise, under argon, stirring and React for 2 hours at a temperature of 80°C. After 2 hours of reaction, add the calculated amount of HEMA, and react for 2 hours under argon gas, stirring, and a temperature of 80°C to ensure that the double bonds are terminated. Use a dialysis bag with a molecular weight of 500 for 5 days to remove For unreacted small molecular monomers, use 1:1 ethanol aqueous solution for the first two days, then change to pure water, change the water every 10 hours, and finally centrifuge and dry in a vacuum oven at 50°C to obtain a white powdery double bond End-blocked PEG type polythiourethane;
S2.取0.5g步骤S1制得的双键封端的PEG型聚硫氨酯、0.5g丙烯酸单体溶于2.5gDMF中,首次超声处理(40-100w、20-40kHz)10-30min得混合液,向所述混合液中加入10mg光引发剂Darocur 1173和10mg交联剂TEGDMA,再次超声处理(40-100w、20-40kHz)20-120s,使之成为透明的前驱体溶液;S2. Take 0.5g of the double-bond-terminated PEG-type polythiourethane prepared in step S1 and 0.5g of acrylic monomer dissolved in 2.5g of DMF, and first ultrasonic treatment (40-100w, 20-40kHz) for 10-30min to obtain a mixed solution 10 mg of photoinitiator Darocur 1173 and 10 mg of crosslinker TEGDMA were added to the mixed solution, and ultrasonic treatment (40-100w, 20-40kHz) was performed for 20-120s again to make it a transparent precursor solution;
S3.将S2中的前驱体溶液倒在一块聚四氟乙烯板上并在其上压上另一块聚四氟乙烯板,使用300-400nm紫外光透过所述聚四氟乙烯板照射所述前驱体溶液1-2h,引发自由基聚合使其凝胶化,即得PEG型聚硫氨酯-丙烯酸复合水凝胶材料。S3. Pour the precursor solution in S2 onto a polytetrafluoroethylene plate and press another polytetrafluoroethylene plate on it, and use 300-400nm ultraviolet light to irradiate the polytetrafluoroethylene plate through the polytetrafluoroethylene plate. Precursor solution for 1-2 hours, initiate free radical polymerization to make it gel, and obtain PEG type polythiourethane-acrylic acid composite hydrogel material.
实施例9Example 9
一种PEG型聚硫氨酯-丙烯酸复合水凝胶材料的制备方法,包括如下步骤:A preparation method of PEG type polythiourethane-acrylic acid composite hydrogel material, comprising the steps:
S1.按照MDI、二巯基乙酸PEG1000酯和HEMA摩尔比3.5:2.0:3.0、三者总质量1g及三者溶于DMF溶剂后固含量为12.2%(DMF溶剂为三种溶质总质量的7.2倍)的要求,计算各原料及溶剂的用量,将计算量的二巯基乙酸PEG1000酯和3.6g DMF加入三口烧瓶,计算量的MDI和3.6g DMF采用滴加的方式加入,在氩气、搅拌和温度为65℃条件下反应2h,反应2h后,加入计算量的HEMA,在氩气、搅拌和温度为65℃条件下反应3h,保证双键封端,采用分子量500的透析袋透析5天除去未反应的小分子单体,其中前面两天采用1:1的乙醇水溶液,后面改为纯水,每隔10h换一次水,最后离心,50℃真空干燥箱干燥,得到白色粉末状的双键封端的PEG型聚硫氨酯;S1. According to MDI, PEG1000 dimercaptoacetic acid ester and HEMA molar ratio 3.5:2.0:3.0, the total mass of the three is 1g and the solid content after the three are dissolved in DMF solvent is 12.2% (DMF solvent is 7.2 times the total mass of the three solutes ), calculate the consumption of each raw material and solvent, add the three-necked flask with the calculated amount of dimercaptoacetic acid PEG1000 ester and 3.6g DMF, the calculated amount of MDI and the 3.6g DMF are added dropwise, under argon, stirring and React for 2 hours at a temperature of 65°C. After 2 hours of reaction, add the calculated amount of HEMA, and react for 3 hours under argon gas, stirring, and a temperature of 65°C to ensure that the double bonds are terminated. Use a dialysis bag with a molecular weight of 500 for 5 days to remove For unreacted small molecular monomers, use 1:1 ethanol aqueous solution for the first two days, then change to pure water, change the water every 10 hours, and finally centrifuge and dry in a vacuum oven at 50°C to obtain a white powdery double bond End-blocked PEG type polythiourethane;
S2.取0.5g步骤S1制得的双键封端的PEG型聚硫氨酯、0.5g丙烯酸单体溶于3.3gDMF中,首次超声处理(40-100w、20-40kHz)10-30min得混合液,向所述混合液中加入12mg光引发剂Darocur 1173和12mg交联剂TEGDMA,再次超声处理(40-100w、20-40kHz)20-120s,使之成为透明的前驱体溶液;S2. Take 0.5g of the double-bond-terminated PEG-type polythiourethane prepared in step S1 and 0.5g of acrylic monomer dissolved in 3.3g of DMF, and first ultrasonic treatment (40-100w, 20-40kHz) for 10-30min to obtain a mixed solution 12 mg of photoinitiator Darocur 1173 and 12 mg of crosslinker TEGDMA were added to the mixed solution, and ultrasonic treatment (40-100w, 20-40kHz) was performed for 20-120s again to make it a transparent precursor solution;
S3.将S2中的前驱体溶液倒在一块聚四氟乙烯板上并在其上压上另一块聚四氟乙烯板,使用300-400nm紫外光透过所述聚四氟乙烯板照射所述前驱体溶液1-2h,引发自由基聚合使其凝胶化,即得PEG型聚硫氨酯-丙烯酸复合水凝胶材料。S3. Pour the precursor solution in S2 onto a polytetrafluoroethylene plate and press another polytetrafluoroethylene plate on it, and use 300-400nm ultraviolet light to irradiate the polytetrafluoroethylene plate through the polytetrafluoroethylene plate. Precursor solution for 1-2 hours, initiate free radical polymerization to make it gel, and obtain PEG type polythiourethane-acrylic acid composite hydrogel material.
实施例10Example 10
一种PEG型聚硫氨酯-丙烯酸复合水凝胶材料的制备方法,包括如下步骤:A preparation method of PEG type polythiourethane-acrylic acid composite hydrogel material, comprising the steps:
S1.按照HDI、二巯基乙酸PEG1000酯和HEMA摩尔比3.0:2.0:2.0、三者总质量1g及三者溶于DMF溶剂后固含量为40%(DMF溶剂为三种溶质总质量的1.5倍)的要求,计算各原料及溶剂的用量,将计算量的二巯基乙酸PEG1000酯和0.75g DMF加入三口烧瓶,计算量的HDI和0.75g DMF采用滴加的方式加入,在氩气、搅拌和温度为55℃条件下反应3h,反应2h后,加入计算量的HEMA,在氩气、搅拌和温度为55℃条件下反应3h,保证双键封端,采用分子量500的透析袋透析5天除去未反应的小分子单体,其中前面两天采用1:1的乙醇水溶液,后面改为纯水,每隔10h换一次水,最后离心,50℃真空干燥箱干燥,得到白色粉末状的双键封端的PEG型聚硫氨酯;S1. According to HDI, PEG1000 dimercaptoacetic acid ester and HEMA molar ratio 3.0:2.0:2.0, the total mass of the three is 1g and the solid content after the three are dissolved in DMF solvent is 40% (DMF solvent is 1.5 times the total mass of the three solutes ), calculate the consumption of each raw material and solvent, add the three-necked flask with the calculated amount of dimercaptoacetic acid PEG1000 ester and 0.75g DMF, and add the calculated amount of HDI and 0.75g DMF in a dropwise manner, under argon, stirring and React for 3 hours at a temperature of 55°C. After 2 hours of reaction, add the calculated amount of HEMA, and react for 3 hours under argon gas, stirring, and a temperature of 55°C to ensure that the double bonds are terminated. Use a dialysis bag with a molecular weight of 500 for 5 days to remove For unreacted small molecular monomers, use 1:1 ethanol aqueous solution for the first two days, then change to pure water, change the water every 10 hours, and finally centrifuge and dry in a vacuum oven at 50°C to obtain a white powdery double bond End-blocked PEG type polythiourethane;
S2.取0.29g步骤S1制得的双键封端的PEG型聚硫氨酯、0.71g丙烯酸单体溶于2.1gDMF中,首次超声处理(40-100w、20-40kHz)10-30min得混合液,向所述混合液中加入9mg光引发剂Darocur 1173和9mg交联剂TEGDMA,再次超声处理(40-100w、20-40kHz)20-120s,使之成为透明的前驱体溶液;S2. Take 0.29g of the double-bond-terminated PEG-type polythiourethane prepared in step S1, and dissolve 0.71g of acrylic acid monomer in 2.1g of DMF, and perform the first ultrasonic treatment (40-100w, 20-40kHz) for 10-30min to obtain a mixed solution , add 9 mg of photoinitiator Darocur 1173 and 9 mg of crosslinker TEGDMA to the mixed solution, and ultrasonicate again (40-100w, 20-40kHz) for 20-120s to make it a transparent precursor solution;
S3.将S2中的前驱体溶液倒在一块聚四氟乙烯板上并在其上压上另一块聚四氟乙烯板,使用300-400nm紫外光透过所述聚四氟乙烯板照射所述前驱体溶液1-2h,引发自由基聚合使其凝胶化,即得PEG型聚硫氨酯-丙烯酸复合水凝胶材料。S3. Pour the precursor solution in S2 onto a polytetrafluoroethylene plate and press another polytetrafluoroethylene plate on it, and use 300-400nm ultraviolet light to irradiate the polytetrafluoroethylene plate through the polytetrafluoroethylene plate. Precursor solution for 1-2 hours, initiate free radical polymerization to make it gel, and obtain PEG type polythiourethane-acrylic acid composite hydrogel material.
实施例11Example 11
一种PEG型聚硫氨酯-丙烯酸复合水凝胶材料的制备方法,包括如下步骤:A preparation method of PEG type polythiourethane-acrylic acid composite hydrogel material, comprising the steps:
S1.按照MDI、二巯基乙酸PEG1500酯和HEMA摩尔比3:2:2.5、三者总质量1g及三者溶于DMF溶剂后固含量为5.3%(DMF溶剂为三种溶质总质量的17倍)的要求,计算各原料及溶剂的用量,将计算量的二巯基乙酸PEG1500酯和8.5g DMF加入三口烧瓶,计算量的MDI和8.5g DMF采用滴加的方式加入,在氩气、搅拌和温度为75℃条件下反应2h,反应2h后,加入计算量的HEMA,在氩气、搅拌和温度为75℃条件下反应2h,保证双键封端,采用分子量500的透析袋透析5天除去未反应的小分子单体,其中前面两天采用1:1的乙醇水溶液,后面改为纯水,每隔10h换一次水,最后离心,50℃真空干燥箱干燥,得到白色粉末状的双键封端的PEG型聚硫氨酯;S1. According to MDI, PEG1500 dimercaptoacetic acid ester and HEMA molar ratio 3:2:2.5, the total mass of the three is 1g and the solid content after the three are dissolved in DMF solvent is 5.3% (DMF solvent is 17 times the total mass of the three solutes ), calculate the consumption of each raw material and solvent, add the three-necked flask with the calculated amount of dimercaptoacetic acid PEG1500 ester and 8.5g DMF, the calculated amount of MDI and the 8.5g DMF are added dropwise, under argon, stirring and React for 2 hours at a temperature of 75°C. After 2 hours of reaction, add the calculated amount of HEMA, and react for 2 hours under argon gas, stirring, and a temperature of 75°C to ensure that the double bonds are terminated. Use a dialysis bag with a molecular weight of 500 for 5 days to remove For unreacted small molecular monomers, use 1:1 ethanol aqueous solution for the first two days, then change to pure water, change the water every 10 hours, and finally centrifuge and dry in a vacuum oven at 50°C to obtain a white powdery double bond End-blocked PEG type polythiourethane;
S2.取0.29g步骤S1制得的双键封端的PEG型聚硫氨酯、0.71g丙烯酸单体溶于1.9gDMF中,首次超声处理(40-100w、20-40kHz)10-30min得混合液,向所述混合液中加入9.1mg光引发剂Darocur 1173和9.1mg交联剂TEGDMA,再次超声处理(40-100w、20-40kHz)20-120s,使之成为透明的前驱体溶液;S2. Take 0.29g of the double-bond-terminated PEG-type polythiourethane prepared in step S1 and 0.71g of acrylic monomer dissolved in 1.9g of DMF, and first ultrasonic treatment (40-100w, 20-40kHz) for 10-30min to obtain a mixed solution , add 9.1 mg of photoinitiator Darocur 1173 and 9.1 mg of crosslinker TEGDMA to the mixed solution, and ultrasonicate again (40-100w, 20-40kHz) for 20-120s to make it a transparent precursor solution;
S3.将S2中的前驱体溶液倒在一块聚四氟乙烯板上并在其上压上另一块聚四氟乙烯板,使用300-400nm紫外光透过所述聚四氟乙烯板照射所述前驱体溶液1-2h,引发自由基聚合使其凝胶化,即得PEG型聚硫氨酯-丙烯酸复合水凝胶材料。S3. Pour the precursor solution in S2 onto a polytetrafluoroethylene plate and press another polytetrafluoroethylene plate on it, and use 300-400nm ultraviolet light to irradiate the polytetrafluoroethylene plate through the polytetrafluoroethylene plate. Precursor solution for 1-2 hours, initiate free radical polymerization to make it gel, and obtain PEG type polythiourethane-acrylic acid composite hydrogel material.
实施例12Example 12
一种PEG型聚硫氨酯-丙烯酸复合水凝胶材料的制备方法,包括如下步骤:A preparation method of PEG type polythiourethane-acrylic acid composite hydrogel material, comprising the steps:
S1.按照IPDI、二巯基乙酸PEG1500酯和HEMA摩尔比3.5:2:2.5、三者总质量1g及三者溶于DMF溶剂后固含量为12.8%(DMF溶剂为三种溶质总质量的6.8倍)的要求,计算各原料及溶剂的用量,将计算量的二巯基乙酸PEG1500酯和3.4g DMF加入三口烧瓶,计算量的IPDI和3.4g DMF采用滴加的方式加入,在氩气、搅拌和温度为60℃条件下反应2h,反应2h后,加入计算量的HEMA,在氩气、搅拌和温度为60℃条件下反应2h,保证双键封端,采用分子量500的透析袋透析5天除去未反应的小分子单体,其中前面两天采用1:1的乙醇水溶液,后面改为纯水,每隔10h换一次水,最后离心,50℃真空干燥箱干燥,得到白色粉末状的双键封端的PEG型聚硫氨酯;S1. According to IPDI, PEG1500 dimercaptoacetic acid ester and HEMA molar ratio 3.5:2:2.5, the total mass of the three is 1g and the solid content after the three are dissolved in DMF solvent is 12.8% (DMF solvent is 6.8 times the total mass of the three solutes ), calculate the consumption of each raw material and solvent, add the three-necked flask with the calculated amount of dimercaptoacetic acid PEG1500 ester and 3.4g DMF, the calculated amount of IPDI and the 3.4g DMF adopt the mode of adding dropwise, under argon, stirring and React for 2 hours at a temperature of 60°C. After 2 hours of reaction, add the calculated amount of HEMA, and react for 2 hours under argon, stirring, and a temperature of 60°C to ensure that the double bonds are terminated. Use a dialysis bag with a molecular weight of 500 for 5 days to remove For unreacted small molecular monomers, use 1:1 ethanol aqueous solution for the first two days, then change to pure water, change the water every 10 hours, and finally centrifuge and dry in a vacuum oven at 50°C to obtain a white powdery double bond End-blocked PEG type polythiourethane;
S2.取0.29g步骤S1制得的双键封端的PEG型聚硫氨酯、0.71g丙烯酸单体溶于3.2gDMF中,首次超声处理(40-100w、20-40kHz)10-30min得混合液,向所述混合液中加入12mg光引发剂Darocur 1173和12mg交联剂TEGDMA,再次超声处理(40-100w、20-40kHz)20-120s,使之成为透明的前驱体溶液;S2. Take 0.29g of the double-bond-terminated PEG-type polythiourethane prepared in step S1, and dissolve 0.71g of acrylic acid monomer in 3.2g of DMF, and perform the first ultrasonic treatment (40-100w, 20-40kHz) for 10-30min to obtain a mixed solution 12 mg of photoinitiator Darocur 1173 and 12 mg of crosslinker TEGDMA were added to the mixed solution, and ultrasonic treatment (40-100w, 20-40kHz) was performed for 20-120s again to make it a transparent precursor solution;
S3.将S2中的前驱体溶液倒在一块聚四氟乙烯板上并在其上压上另一块聚四氟乙烯板,使用300-400nm紫外光透过所述聚四氟乙烯板照射所述前驱体溶液1-2h,引发自由基聚合使其凝胶化,即得PEG型聚硫氨酯-丙烯酸复合水凝胶材料。S3. Pour the precursor solution in S2 onto a polytetrafluoroethylene plate and press another polytetrafluoroethylene plate on it, and use 300-400nm ultraviolet light to irradiate the polytetrafluoroethylene plate through the polytetrafluoroethylene plate. Precursor solution for 1-2 hours, initiate free radical polymerization to make it gel, and obtain PEG type polythiourethane-acrylic acid composite hydrogel material.
性能检测performance testing
测试实施例1至12制备的PEG型聚硫氨酯-丙烯酸复合水凝胶材料的平衡含水量及平衡含水状态下的折射率、干燥状态下的折射率。将各实施例制备的PEG型聚硫氨酯-丙烯酸复合水凝胶材料分别放到大量的水中清洗,使水凝胶中未反应的溶解性物质交换出,之后用去离子水至少浸泡3天,使其达到平衡含水状态测试其平衡含水状态折射率和含水率(Nd湿),之后按照常规方法及要求对其进行干燥,干燥后测试其干燥状态时的折射率(Nd干),每个实施例的样品测4次,再取平均值,测得的相应结果如下表所示:The equilibrium water content, the refractive index in the equilibrium water-containing state, and the refractive index in the dry state of the PEG-type polythiourethane-acrylic acid composite hydrogel materials prepared in Examples 1 to 12 were tested. Put the PEG-type polythiourethane-acrylic acid composite hydrogel materials prepared in each embodiment into a large amount of water to wash, so that the unreacted soluble substances in the hydrogel are exchanged, and then soak them in deionized water for at least 3 days , to make it reach the equilibrium water-containing state and test its equilibrium water-containing state refractive index and moisture content (Nd wet ), then dry it according to conventional methods and requirements, and test its dry state refractive index (Nd dry ) after drying, each The sample of embodiment measures 4 times, gets average value again, and the corresponding result of measuring is shown in the following table:
从上表的数据中可知,本发明制备出的PEG型聚硫氨酯-丙烯酸复合水凝胶材料的平衡含水量、干折射率、湿折射率均较高,控制丙烯酸在水凝胶里的含量可调整水凝胶的平衡含水量和折射率,通过加入不同芳环、脂肪结构的异氰酸以及通过改变分子链中软硬段的组成也可对水凝胶的折射率和含水量进行一定的调控,另外,通过控制PEG型聚硫氨酯中PEG的分子量也可以适当调控最终的复合水凝胶的折射率和平衡含水量;实际生产中,可根据需要对合成原料及其用量进行调整,以获得具有特定平衡含水量和折射率的水凝胶材料;本发明制得的复合水凝胶材料在作为软质隐形眼镜材料和人工眼角膜植入材料方面具有很大的潜在应用。As can be seen from the data in the table above, the equilibrium water content, dry refractive index, and wet refractive index of the PEG type polythiourethane-acrylic acid composite hydrogel material prepared by the present invention are all higher, and the content of acrylic acid in the hydrogel is controlled. The content can adjust the equilibrium water content and refractive index of the hydrogel, and the refractive index and water content of the hydrogel can also be adjusted by adding isocyanic acid with different aromatic rings and aliphatic structures and by changing the composition of the soft and hard segments in the molecular chain. Certain regulation, in addition, by controlling the molecular weight of PEG in PEG type polythiourethane also can suitably regulate and control the refractive index and the equilibrium water content of final composite hydrogel; Adjust to obtain a hydrogel material with a specific balance of water content and refractive index; the composite hydrogel material prepared by the present invention has great potential applications as soft contact lens materials and artificial corneal implant materials.
以上所述仅为本发明的较佳实施例,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。The above descriptions are only preferred embodiments of the present invention, and are not intended to limit the present invention. Any modifications, equivalent replacements, improvements, etc. made within the spirit and principles of the present invention shall be included in the protection of the present invention. within range.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610542009.4A CN106188411B (en) | 2016-07-11 | 2016-07-11 | A kind of PEG types polythiourethane-acrylic acid compound hydrogel material and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610542009.4A CN106188411B (en) | 2016-07-11 | 2016-07-11 | A kind of PEG types polythiourethane-acrylic acid compound hydrogel material and its preparation method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106188411A true CN106188411A (en) | 2016-12-07 |
CN106188411B CN106188411B (en) | 2018-09-28 |
Family
ID=57476970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610542009.4A Expired - Fee Related CN106188411B (en) | 2016-07-11 | 2016-07-11 | A kind of PEG types polythiourethane-acrylic acid compound hydrogel material and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106188411B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107625992A (en) * | 2017-10-01 | 2018-01-26 | 刘云晖 | A kind of soluble dressing and preparation method thereof |
CN110917410A (en) * | 2019-11-14 | 2020-03-27 | 浙江大学 | A kind of cardiovascular stent coating based on double-layer heterogeneous structure and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101702038A (en) * | 2009-11-10 | 2010-05-05 | 张建兴 | Resin lens with high impact resistance |
CN101702039A (en) * | 2009-11-10 | 2010-05-05 | 张建兴 | Resin lens with high impact resistance |
CN101712742A (en) * | 2009-11-10 | 2010-05-26 | 江阴市茂盛光学材料有限公司 | Solution of sulfhydryl-containing terminated polythiourethane prepolymer and preparation method thereof |
CN102827389A (en) * | 2011-06-14 | 2012-12-19 | 埃西勒国际通用光学公司 | Lens manufacturing method |
WO2014074550A1 (en) * | 2012-11-06 | 2014-05-15 | Ppg Industries Ohio, Inc. | Polymerizable compositions and optical articles prepared therefrom |
-
2016
- 2016-07-11 CN CN201610542009.4A patent/CN106188411B/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101702038A (en) * | 2009-11-10 | 2010-05-05 | 张建兴 | Resin lens with high impact resistance |
CN101702039A (en) * | 2009-11-10 | 2010-05-05 | 张建兴 | Resin lens with high impact resistance |
CN101712742A (en) * | 2009-11-10 | 2010-05-26 | 江阴市茂盛光学材料有限公司 | Solution of sulfhydryl-containing terminated polythiourethane prepolymer and preparation method thereof |
CN102827389A (en) * | 2011-06-14 | 2012-12-19 | 埃西勒国际通用光学公司 | Lens manufacturing method |
WO2014074550A1 (en) * | 2012-11-06 | 2014-05-15 | Ppg Industries Ohio, Inc. | Polymerizable compositions and optical articles prepared therefrom |
Non-Patent Citations (2)
Title |
---|
CHANGLI LU¨,等: "High refractive index thin films of ZnS/polythiourethane", 《JOURNAL OF MATERIALS CHEMISTRY》 * |
张全元,等: "高折射水凝胶型人工角膜材料", 《2015年全国高分子学术论文报告会》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107625992A (en) * | 2017-10-01 | 2018-01-26 | 刘云晖 | A kind of soluble dressing and preparation method thereof |
CN107625992B (en) * | 2017-10-01 | 2020-05-08 | 山东朱氏堂医疗器械有限公司 | Soluble dressing and preparation method thereof |
CN110917410A (en) * | 2019-11-14 | 2020-03-27 | 浙江大学 | A kind of cardiovascular stent coating based on double-layer heterogeneous structure and preparation method thereof |
CN110917410B (en) * | 2019-11-14 | 2020-11-24 | 浙江大学 | A kind of cardiovascular stent coating based on double-layer heterogeneous structure and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN106188411B (en) | 2018-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | Antifouling super water absorbent supramolecular polymer hydrogel as an artificial vitreous body | |
JP2002506690A (en) | Methods for producing intraocular lenses and materials suitable for their production | |
US20240197964A1 (en) | Gel material for ophthalmic treatment use | |
CN106999270A (en) | The amphion of functionalization and hybrid charge polymer, related hydrogel and their application method | |
KR20160149209A (en) | (meth)acrylamid polymers for contact lens and intraocular lens | |
Liang et al. | Synthesis and characterization of in situ forming anionic hydrogel as vitreous substitutes | |
US10653783B2 (en) | Sustained release of bioactive factors from zwitterionic hydrogels | |
CN107383397A (en) | To aoxidize hydroxyethyl cellulose as derivatives of hyaluronic acids self-crosslinking hydrogel of crosslinking agent and preparation method thereof | |
Wang et al. | In-situ forming PEG-engineering hydrogels with anti-fouling characteristics as an artificial vitreous body | |
TW201836652A (en) | Ophthalmic lens and manufacturing method thereof | |
CN106188411B (en) | A kind of PEG types polythiourethane-acrylic acid compound hydrogel material and its preparation method and application | |
CN106413755B (en) | Medical instrument containing negative ionic drugs | |
Annaka et al. | Organic–inorganic nanocomposite gels as an in situ gelation biomaterial for injectable accommodative intraocular lens | |
CN110511400A (en) | Copolymer photoreversible hydrogel based on zwitterionic compound and coumarin derivative and its preparation method | |
US11034801B2 (en) | Transparent hydrogel membrane including hyaluronic acid, and contact lens including same | |
CN106065050B (en) | A kind of polythiourethane acrylic acid zinc sulphide compound hydrogel material and its preparation method and application | |
Hong et al. | Polymers of 1-vinyl-2-pyrrolidinone as potential vitreous substitutes: physical selection | |
Xu et al. | Carbazole-grafted silicone hydrogel with a high refractive index for intraocular lens | |
Yang et al. | Fabrication of carboxymethyl cellulose-based thermo-sensitive hydrogels and inhibition of corneal neovascularization | |
CN106188409B (en) | A kind of polythiourethane-acrylic acid compound hydrogel material and its preparation method and application | |
CN109481339A (en) | A kind of collagen-based composite hydrogel face-mask material and its preparation method and application | |
CN115710329B (en) | Flexible hydrophilic contact lens containing ectoin and preparation method thereof | |
CN114545658B (en) | A preparation method of drug sustained-release interpenetrating network hydrogel contact lens | |
CN105504151A (en) | Preparation method and application of high-refraction hydrogel type nano-composites | |
JP6856019B2 (en) | Ocular lens and its manufacturing method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180928 Termination date: 20190711 |